Paper
The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
Published Mar 1, 2009 · A. Javeed, Baojun Zhang, Yanyan Qu
Transplant immunology
Q2 SJR score
26
Citations
1
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Non-RCT
Animal StudyStudy Snapshot
Aspirin treatment at therapeutic doses significantly increases the frequency of functional CD4+CD25+Foxp3+ Treg cells, potentially benefiting tolerance induction in patients with autoimmune diseases or allo-grafts.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
The different effects of indirubin on effector and CD4+CD25+ regulatory T cells in mice: potential implication for the treatment of autoimmune diseases
Indirubin selectively enhances CD4+CD25+Treg cell levels, potentially making it a potential treatment for autoimmune diseases by promoting immune tolerance induction.
2007·27citations·Aijun Zhang et al.·Journal of Molecular Medicine
Journal of Molecular Medicine
The regulation of Foxp3 expression in regulatory CD4+CD25+T cells: Multiple pathways on the road
Recent advances in understanding the regulatory roles of T-cell receptor, co-stimulatory molecules, IL-2, TGF-, and beyond on Foxp3 expression in regulatory T cells have led to improved understanding of its development and function.
2007·181citations·Lianjun Zhang et al.·Journal of Cellular Physiology
Journal of Cellular Physiology
Changes of CD4+CD25+Foxp3+ regulatory T cells in aged Balb/c mice
Aging in mice leads to altered levels, phenotypes, and function of CD4+CD25+ Treg cells, potentially contributing to increased sensitivity to autoimmune diseases.
2007·148citations·Liang Zhao et al.·Journal of Leukocyte Biology
Journal of Leukocyte Biology
Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide‐induced experimental autoimmune thyroiditis in human leucocyte antigen DR3 (DRB1*0301) transgenic class II‐knock‐out non‐obese diabetic mice
Depletion of CD4+CD25+ regulatory T cells exacerbates sodium iodide-induced experimental autoimmune thyroiditis in HLA class II transgenic mice.
2007·48citations·J. Flynn et al.·Clinical & Experimental Immunology
Clinical & Experimental Immunology
A Potential Side Effect of Cyclosporin A: Inhibition of CD4+CD25+ Regulatory T Cells in Mice
Cyclosporin A significantly impairs the development and function of CD4+CD25+ regulatory T cells, potentially increasing susceptibility to autoimmune diseases while preventing graft rejection.
2006·99citations·Hongjun Wang et al.·Transplantation
Transplantation
Citations
A comprehensive review of the roles of T-cell immunity in preeclampsia
T-cell immunity plays a crucial role in preeclampsia, and targeting it may offer potential preventive and therapeutic strategies, but safety is crucial for both mothers and infants.
2025·0citations·Xu Peng et al.·Frontiers in Immunology
Frontiers in Immunology
2-(3-(chloromethyl)benzoyloxy)benzoic Acid Increases CD4+ Regulatory T-Cell Population and FoxP3 Expression in Lipopolysaccharide-induced Mice
3-CH2Cl may reduce inflammation by decreasing CD4+ T-cell population and increasing CD4+ Treg population in LPS-induced mice, with potential therapeutic applications.
2023·5citations·Yudy Tjahjono et al.·The Indonesian Biomedical Journal
The Indonesian Biomedical Journal
The impact of metformin and aspirin on T-cell mediated inflammation: A systematic review of in vitro and in vivo findings.
Metformin and aspirin both reduce T-cell mediated inflammation in type 2 diabetes patients, potentially improving cardiovascular complications management.
2020·23citations·T. M. Nyambuya et al.·Life sciences
Life sciences
Unexpected effects of long-term treatment with acetylsalicylic acid on late phase of pulmonary metastasis in murine model of orthotopic breast cancer
Long-term treatment with low-dose aspirin in a mouse orthotopic breast cancer model negatively affected the disease phenotype, suggesting it may not be a selective platelet COX-1/TXA2 pathway inhibitor.
2020·6citations·M. Smęda et al.·PLoS ONE
PLoS ONE
Effect of selected non-steroidal anti-inflammatory drugs on activation-induced CD25 expression on murine CD4+ and CD8+ T cells: an in vitro study
Non-selective COX inhibitors and selective COX-2 inhibitors may weaken the effector T cell response by reducing the count of activated effector T cells, while ASA has no effect on CD25 expression on CD4+ and CD8+ T cells.
2019·11citations·I. Gregorczyk et al.·Central-European Journal of Immunology
Central-European Journal of Immunology
In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs.
Low-dose aspirin combined with cyclosporine effectively suppresses T-cell cytokine production in dogs without significantly altering the immunosuppressive mechanism of action of cyclosporine.
2018·15citations·T. Archer et al.·Veterinary immunology and immunopathology
Veterinary immunology and immunopathology
Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
Aspirin use is stronger in patients with CD274-low tumors than CD274-high tumors, suggesting a differential antitumor effect based on immune checkpoint status.
2017·111citations·Tsuyoshi Hamada et al.·Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Screening Immunomodulators To Skew the Antigen-Specific Autoimmune Response.
Dexamethasone shows potential in inducing antigen-specific immune tolerance by skewing cytokine response and decreasing T-cell populations in autoimmune encephalomyelitis mice.
2017·5citations·L. Northrup et al.·Molecular pharmaceutics
Molecular pharmaceutics